For 3QFY2024, the group’s earnings excluding exceptional items (EI) saw a 43% y-o-y increase to RM528 million on stronger core operational growth.
IHH Healthcare has reported patmi of RM534 million ($161.5 million) for the 3QFY2024 ended September, remaining flat as compared to RM532.1 million in 3QFY2023. Ebitda fell by 9% y-o-y to RM1.3 billion within the same period.
On a year-to-date (ytd) basis, the group also reported patmi of RM1.9 billion, down 13% y-o-y from the same period last year.
